Evidence map›Paper›PMID 40163084›Full record

SynthesisJAMA internal medicine2025

Inclusion of Retracted Studies in Systematic Reviews and Meta-Analyses of Interventions: A Systematic Review and Meta-Analysis.

Carolina Graña Possamai, Guillaume Cabanac, Elodie Perrodeau, Lina Ghosn, Philippe Ravaud, Isabelle Boutron

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. [Scientific fraud and dubious publication practices].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Carolina Graña PossamaiUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
Guillaume CabanacUniversité Toulouse 3-Paul Sabatier, IRIT UMR 5505 CNRS, Toulouse, France.
Elodie PerrodeauUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
Lina GhosnUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
Philippe RavaudUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
Isabelle BoutronUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Retractions are rising in the scientific literature, increasing the risk of reusing unreliable results. Objectives: To identify reports of systematic reviews that included retracted studies in their meta-analyses, and to assess the impact of these retracted studies on the results. Design, Setting, and Participants: In this systematic review and meta-analysis the Feet of Clay Detector tool was searched to identify all systematic reviews that reported at least 1 meta-analysis including at least 1 retracted study and were published in the 25 highest impact factor journals in medicine, general and internal, from January 2013 to April 2024. All effect estimates where the retracted study contributed to the analysis were identified. For each meta-analysis, the summary effect, including all studies and excluding retracted studies was calculated. The search was conducted on April 8, 2024. Results: Overall, 61 systematic reviews were identified that included retracted studies in their meta-analyses. Of these, 11 (18%) have been republished, retracted, or withdrawn. Data were extracted from 50 systematic reviews that included a total of 62 retracted studies. Retraction occurred after the publication in 37 systematic reviews (74%). Overall, 173 meta-analyses including the retracted study were identified; 70 of them (40%) were primary outcomes. One-hundred sixty-six meta-analyses were recalculated. Overall, 160 (96%) of the 166 recalculated effect estimates were within the CIs of the original effect. After exclusion of the retracted study, the statistical significance of the results changed in 18 meta-analyses (11%). The rate of evolution between effect estimates with and without retracted studies for 163 meta-analyses overall were calculated, including 64 addressing the primary outcomes of the systematic reviews. For primary outcomes (n = 64), the recalculated effect estimates changed by at least 10% in 27 meta-analyses (42%), 30% in 16 (25%), and 50% in 12 (19%). Overall (n = 163), effect estimates changed by at least 10% in 57 meta-analyses (35%), 30% in 31 (19%), and 50% in 23 (14%). Conclusions and Relevance: This study found that retracted studies have been included in systematic reviews and meta-analyses, with retractions occurring mainly after the publication of the systematic review. The inclusion of retracted studies can impact the results and interpretation of reviews. Quality control measures should be implemented to prevent the dissemination of unreliable data in scientific literature.

Indexed as

Meta-Analysis as TopicRetraction of Publication as TopicSystematic Reviews as TopicHumans

Identifiers

PMID40163084
PMCPMC11959482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.